At the department of Hematology we are dedicated to improving the diagnosis and treatment of patients with hematological diseases. We perform basic and translational research to generate insight into the pathobiology of hematological diseases, and translate these findings into novel treatments for our patients.
In addition, we direct a wide variety of clinical studies, closely linked to our preclinical programs. These clinical studies deal with the development of molecular diagnostics, advancement of allogeneic stem cell transplantation, circumvention of drug-resistance to chemotherapy as well as a broad range of clinical phase I to phase III trials for a variety of hematological diseases.
For more information on clinical care for patients with hematological diseases please see our clinical homepage.
On October 20-24 Tim van Tienhoven attended the 2025 FEBS Workshop on the Molecular and Cellular Pathways of Aging in Hematopoiesis in Crete, Greece. He had already received a grant to attend, as well as both a poster presentation and a short oral presentation. Here, he presented his work titled "Targeting mitochondria mitigates chemotherapy-induced bone marrow dysfunction."
Mandy Lauw (internist-hematologist) received the EHA YoungEHA Award during the recent European Hematology Association (EHA) congress in Milan.
PhD candidate Sophie Hordijk has been selected as one of the five recipients of the Professor Heimburger Award 2025, presented by global biotechnology company CSL Behring. This award, which includes a €25,000 grant, celebrates outstanding clinical and preclinical research by early-career scientists working to improve care for patients with bleeding disorders.
The Erasmus MC Hematology Department is excited to announce our new fall lecture series!Starting on September 1st, there will be webinars from excellent researchers covering a wide range of hematological (and related) topics. The series will start with Mark Dawson.
Drs Meltem Yildirim has been awarded the Mosaic 2.0 Grant for research on the role of inflammation in TP53-mutant cancer evolution, with the invaluable support and guidance of Dr Mathijs Sanders and Prof Dr Marc Raaijmakers.
Minke Rab (internist-hematologist and scientist) has been awarded the EHA Topic-In-Focus Physician Scientist Research Grant at the recent European Hematology Association (EHA) Congress in Milan.
The Spring digital lecture series starts on January 27th.
Everyone is invited to attend. Registration not necessary and attendance is free of charge.
If want to be updated on our lecture series and receive the links, subscribe to our newsletter here.
The 8th workshop on “Molecular aspects of hematological malignancies” will take place on 10 and 11 June in Rotterdam. This meeting is meant to give young investigators (PhD's or Postdocs) a platform to present their most recent work. It is a perfect moment for young investigators in our field to meet and create their own network.
You can find more information on the workshop website.
